Shopping Cart
- Remove All
Your shopping cart is currently empty
APTSTAT3-9R acetate is a selective peptide binding STAT3 with antiproliferative and antitumor activity. APTSTAT3-9R acetate and inhibits STAT3 activation and downstream signaling by specifically blocking STAT3 phosphorylation.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $227 | Backorder | |
| 5 mg | $677 | Backorder | |
| 10 mg | $997 | Backorder | |
| 25 mg | $1,827 | Backorder | |
| 50 mg | $2,742 | Backorder | |
| 100 mg | $4,113 | Backorder |
| Description | APTSTAT3-9R acetate is a selective peptide binding STAT3 with antiproliferative and antitumor activity. APTSTAT3-9R acetate and inhibits STAT3 activation and downstream signaling by specifically blocking STAT3 phosphorylation. |
| In vitro | APTSTAT3-9R acetate (7.5, 15, and 30 μmol/L) significantly reduces STAT3–DNA-binding activity in a dose-dependent manner in human lung carcinoma cells (A549) but does not affect the level of AKT phosphorylation, indicating specificity of the aptide. APTSTAT3-9R acetate (30 μM) suppresses cell viability and proliferation of cancer cells and significantly suppresses colony formation. The IC50s are 10 to 20 μM in A549, B16F1, and HepG2 cells[1]. |
| In vivo | In female BALB/c nude mice with A549 cells, APTSTAT3-9R acetate (8 mg/kg in 50 μL; intratumoral injection) suppresses tumor growth[1]. |
| Molecular Weight | 5007.56 |
| Formula | C225H334N80O53 |
| Sequence | His-Gly-Phe-Gln-Trp-Pro-Gly-Ser-Trp-xiThr-Trp-Glu-Asn-Gly-Lys-Trp-xiThr-Trp-Lys-Gly-Ala-Tyr-Gln-Phe-Leu-Lys-Gly-Gly-Gly-Gly-Ser-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg |
| Sequence Short | HGFQWPGSWXWENGKWXWKGAYQFLKGGGGSRRRRRRRRR |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.